BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 44,983 | $46,782 | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 40 | $42 | 0.00% |
| MORGAN STANLEY | 159,768 | $166,158 | 0.00% |
| BlackRock Inc. | 258,023 | $268,344 | 0.00% |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% |
| JPMORGAN CHASE & CO | 76,287 | $79,339 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VANGUARD GROUP INC | 924,265 | $961,236 | 0.00% |
| FEDERATED HERMES, INC. | 1,161 | $1,207 | 0.00% |
| UBS Group AG | 86 | $89 | 0.00% |
| Squarepoint Ops LLC | 80,037 | $83,238 | 0.00% |
| BARCLAYS PLC | 139 | $0 | 0.00% |
| FMR LLC | 79,196 | $82,364 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 628 | $653 | 0.00% |
| WELLS FARGO & COMPANY/MN | 197 | $205 | 0.00% |
| NORTHERN TRUST CORP | 31,182 | $32,429 | 0.00% |
External links
This page lists BOLT BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view BOLT BIOTHERAPEUTICS INC's shareholder history, click here.